MANILA, PHILIPPINES, SEPTEMBER 10, 2019 – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of Trilogy Evo, the only portable life support ventilator designed to provide consistent therapy and monitoring as care environments or conditions change. Trilogy Evo helps physicians, clinicians and care providers to effectively collaborate and coordinate care by storing patient prescription information in a secure location via the device’s onboard memory. As an integrated platform, Trilogy Evo connects with Care Orchestrator and Care Orchestrator Essence, enabling care teams to download data wirelessly or through a USB, set proactive notifications of changing conditions, and prioritize at-risk patients to help make fast, confident care decisions during a transition of care.
Post-acute care environment transitions and the resulting interruptions in care are often fleeting in time, but their impact can be lasting. Poor transitions lead to unnecessary stress and burden on patients, staff, and caregivers, and can even lead to readmissions. Trilogy Evo was designed to meet the transitional needs of hospital, home, and mobile care. Built on the trusted Trilogy platform, Trilogy Evo also includes AVAPS-AE, a feature that automatically adapts to patients’ changing needs. In fact, 68 percent of surveyed healthcare organizations reported reduced hospital readmissions as a benefit of using Trilogy with AVAPS-AE1.